References

No references inside the corpus for this window.

Cited by

• 2019Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis251 cited
• 2015Promissories and pharmaceutical patents: agencing markets through public narratives62 cited
• 2018How expected outcomes, stakeholders, and institutions influence corporate social responsibility at different levels of large basic needs firms26 cited
• 2023The reputational dividends of collaborating with a highly reputable agency: The case of interagency collaboration between the U.S. FDA and its domestic partner agencies8 cited
• 2024Private consulting firms’ intervention in public health policymaking: An exploratory review4 cited